N-(5-(2-(3-hydroxypiperidin-1-yl)oxazol-5-yl)-4-methylthiazol-2-yl)acetamide

ID: ALA2204794

Chembl Id: CHEMBL2204794

PubChem CID: 71452284

Max Phase: Preclinical

Molecular Formula: C14H18N4O3S

Molecular Weight: 322.39

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)Nc1nc(C)c(-c2cnc(N3CCCC(O)C3)o2)s1

Standard InChI:  InChI=1S/C14H18N4O3S/c1-8-12(22-13(16-8)17-9(2)19)11-6-15-14(21-11)18-5-3-4-10(20)7-18/h6,10,20H,3-5,7H2,1-2H3,(H,16,17,19)

Standard InChI Key:  HDVSIMMLUNLLCM-UHFFFAOYSA-N

Associated Targets(Human)

PIK3CA Tclin PI3-kinase p110-alpha subunit (12269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CG Tclin PI3-kinase p110-gamma subunit (5411 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pik3cg Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (160 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 322.39Molecular Weight (Monoisotopic): 322.1100AlogP: 2.03#Rotatable Bonds: 3
Polar Surface Area: 91.49Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.96CX Basic pKa: 0.25CX LogP: 0.76CX LogD: 0.66
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.90Np Likeness Score: -1.33

References

1. Oka Y, Yabuuchi T, Fujii Y, Ohtake H, Wakahara S, Matsumoto K, Endo M, Tamura Y, Sekiguchi Y..  (2012)  Discovery and optimization of a series of 2-aminothiazole-oxazoles as potent phosphoinositide 3-kinase γ inhibitors.,  22  (24): [PMID:23122859] [10.1016/j.bmcl.2012.10.028]

Source